Gabriel A Wagner
Overview
Explore the profile of Gabriel A Wagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wagner G, Wu K, Anderson C, Burgi A, Little S
Open Forum Infect Dis
. 2023 Mar;
10(3):ofad060.
PMID: 36968957
Background: Improved pre-exposure prophylaxis (PrEP) uptake is essential for human immunodeficiency virus (HIV) prevention initiatives. Offering PrEP at the time of HIV and sexually transmitted infection (STI) testing can improve...
2.
Hoenigl M, Lo M, Coyne C, Wagner G, Blumenthal J, Mathur K, et al.
AIDS Care
. 2021 Nov;
35(5):714-718.
PMID: 34839750
The objective of this study was to determine hospital costs and revenue of universal opt-out HIV ED screening. An electronic medical record (EMR)-directed, automated ED screening program was instituted at...
3.
Mathur K, Blumenthal J, Horton L, Wagner G, Martin T, Lo M, et al.
Acad Emerg Med
. 2020 Dec;
28(8):913-917.
PMID: 33314418
No abstract available.
4.
Hoenigl M, Little S, Grelotti D, Skaathun B, Wagner G, Weibel N, et al.
Clin Infect Dis
. 2019 Nov;
71(7):e135-e140.
PMID: 31677383
Background: Technology has changed the way that men who have sex with men (MSM) seek sex. More than 60% of MSM in the United States use the internet and/or smartphone-based...
5.
Hoenigl M, Mathur K, Blumenthal J, Brennan J, Zuazo M, McCauley M, et al.
Sci Rep
. 2019 Oct;
9(1):14479.
PMID: 31597939
Universal HIV and HCV screening in emergency departments (ED) can reach populations who are less likely to get tested otherwise. The objective of this analysis was to evaluate universal opt-out...
6.
Wagner G, Landais E, Caballero G, Phung P, Kosakovsky Pond S, Poignard P, et al.
J Virol
. 2017 Jun;
91(17).
PMID: 28615205
Understanding whether the neutralizing antibody (NAb) response impacts HIV-1 superinfection and how superinfection subsequently modulates the NAb response can help clarify correlates of protection from HIV exposures and better delineate...
7.
Vesa J, Chaillon A, Wagner G, Anderson C, Richman D, Smith D, et al.
AIDS
. 2017 Mar;
31(8):1149-1158.
PMID: 28244954
Objective: The aim of this study was to characterize the demographic, behavioural, clinical and immunogenetic determinants of HIV-1 superinfection in a high-risk cohort of MSM. Design: A retrospective cohort study...
8.
Wagner G, Chaillon A, Liu S, Franklin Jr D, Caballero G, Kosakovsky Pond S, et al.
AIDS
. 2016 Aug;
30(17):2591-2597.
PMID: 27536983
Objective: Compared with HIV monoinfection, HIV dual infection has been associated with decreased CD4 T-cell counts and increased viral loads. The same markers are also associated with the development of...
9.
Chin B, Shin H, Kim G, Wagner G, Gianella S, Smith D
AIDS Res Hum Retroviruses
. 2015 Apr;
31(6):603-7.
PMID: 25826122
Previous studies reported a relatively low prevalence of transmitted drug resistance (TDR) in South Korea (<5%). A genotypic resistance test was performed on 131 treatment-naive HIV-1-infected individuals from February 2013...
10.
Carter C, Wagner G, Hightower G, Caballero G, Phung P, Richman D, et al.
Virology
. 2014 Dec;
474:34-40.
PMID: 25463602
To better understand the dynamics of HIV-specific neutralizing antibody (NAb), we examined associations between viral genetic diversity and the NAb response against a multi-subtype panel of heterologous viruses in a...